Literature DB >> 18058248

Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' Follow-Up Studies using a multistage carcinogenesis model.

Rafael Meza1, William D Hazelton, Graham A Colditz, Suresh H Moolgavkar.   

Abstract

We analyzed lung cancer incidence among non-smokers, continuing smokers, and ex-smokers in the Nurses Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS) using the two-stage clonal expansion (TSCE) model. Age-specific lung cancer incidence rates among non-smokers are identical in the two cohorts. Within the framework of the model, the main effect of cigarette smoke is on the promotion of partially altered cells on the pathway to cancer. Smoking-related promotion is somewhat higher among women, whereas smoking-related malignant conversion is somewhat lower. In both cohorts the relative risk for a given daily level of smoking is strongly modified by duration. Among smokers, the incidence in NHS relative to that in HPFS depends both on smoking intensity and duration. The age-adjusted risk is somewhat larger in NHS, but not significantly so. After smokers quit, the risk decreases over a period of many years and the temporal pattern of the decline is similar to that reported in other recent studies. Among ex-smokers, the incidence in NHS relative to that in HPFS depends both on previous levels of smoking and on time since quitting. The age-adjusted risk among ex-smokers is somewhat higher in NHS, possibly due to differences in the age-distribution between the two cohorts.

Entities:  

Mesh:

Year:  2007        PMID: 18058248     DOI: 10.1007/s10552-007-9094-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  52 in total

1.  Comparison of mortality and incidence solid cancer risk after radiation exposure in the Techa River Cohort.

Authors:  M Eidemüller; E Ostroumova; L Krestinina; S Epiphanova; A Akleyev; P Jacob
Journal:  Radiat Environ Biophys       Date:  2010-05-12       Impact factor: 1.925

2.  Age-specific incidence of cancer: Phases, transitions, and biological implications.

Authors:  Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar; E Georg Luebeck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

Review 3.  Smoking, air pollution, and lung cancer risk in the Nurses' Health Study cohort: time-dependent confounding and effect modification.

Authors:  Ellen T Chang; Edmund C Lau; Suresh H Moolgavkar
Journal:  Crit Rev Toxicol       Date:  2020-03-12       Impact factor: 5.635

4.  Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model.

Authors:  Summer S Han; S Ayca Erdogan; Iakovos Toumazis; Ann Leung; Sylvia K Plevritis
Journal:  Cancer Causes Control       Date:  2017-07-12       Impact factor: 2.506

Review 5.  Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.

Authors:  Emma Louise O'Dowd; David R Baldwin
Journal:  Br J Radiol       Date:  2017-10-17       Impact factor: 3.039

6.  Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.

Authors:  William J McCarthy; Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

7.  Constraints on data sharing: experience from the nurses' health study.

Authors:  Graham A Colditz
Journal:  Epidemiology       Date:  2009-03       Impact factor: 4.822

8.  Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence.

Authors:  Andrew F Brouwer; Marisa C Eisenberg; Rafael Meza
Journal:  Cancer Res       Date:  2018-06-15       Impact factor: 12.701

9.  Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Authors:  Kevin Ten Haaf; Harry J de Koning
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

10.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.

Authors:  Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis
Journal:  Cancer       Date:  2014-02-27       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.